You are in: eMedicine Specialties > Sports Medicine > Wrist and Hand Wrist DislocationArticle Last Updated: Feb 10, 2006AUTHOR AND EDITOR INFORMATIONAuthor: Kadeer M Halimi, DO, Department of Emergency Medicine, Texas A&M University Health Sciences Center Kadeer M Halimi is a member of the following medical societies: American College of Emergency Physicians Coauthor(s): Thomas Russell Jones, MD, FAAEM, Consulting Staff, Department of Emergency Medicine, Providence Hospital, Waco, TX; Derek K Lichota, MD, Assistant Professor, Department of Surgery, Texas A&M University College of Medicine; Senior Staff, Department of Orthopedics, Division of Sports Medicine, Scott and White Memorial Hospital Editors: Craig C Young, MD, Associate Professor, Departments of Orthopedic Surgery and Family and Community Medicine, Medical Director of Sports Medicine, Sports Medicine Fellowship Director, Medical College of Wisconsin; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Russell D White, MD, Professor of Medicine, Department of Community and Family Medicine, University of Missouri-Kansas City School of Medicine, Truman Medical Center Lakewood; Jon Whitehurst, MD, Consulting Staff, Rockford Orthopedic Associates; Wylie D Lowery Jr, MD, Associate Professor, Department of Orthopedic Surgery, George Washington University Author and Editor Disclosure Synonyms and related keywords: lunate dislocation, perilunate dislocation, scapholunate dislocation, hyperextension injury of the wrist, carpal injury INTRODUCTIONBackgroundWrist injuries are common among athletes. Emergency physicians or family practitioners frequently perform the initial evaluation of wrist injuries and determine the initial treatment. Recognizing wrist dislocations early and properly referring patients with wrist dislocations can prevent complications, including prolonged pain and discomfort, surgery, and lost time from sports participation. FrequencyUnited StatesIn a study by Larsen, as many as 2.5% of all ED visits were made by patients with wrist injuries. A small number of those patients present with wrist dislocations. Subluxations and dislocations account for 10% of carpal injuries, with perilunate dislocation being the most common type of dislocation (Schwartz, 2000). Functional AnatomyThe wrist joint is composed of distal radial and ulnar surfaces, 8 carpal bones, and the proximal metacarpal bones. The distal carpal row consists of the following bones: hamate, capitate, trapezoid, and trapezium. The proximal row consists of the following bones: scaphoid, lunate, triquetrum, and pisiform. The carpal bones are held together by a complex set of ligaments, including the interosseous, volar, and dorsal ligaments and a triangular fibrocartilage complex (TFC). The dorsal ligaments are weaker than the volar ligaments, making dorsal dislocation more common (Schwartz, 2000). Sport Specific BiomechanicsThe mechanism of injury usually is a fall on an outstretched hand resulting in a hyperextension type of injury to the wrist. High energy is a common characteristic feature in all these injuries (Chun-Ying, 2004). The distal row of carpal bones commonly is displaced dorsal to the proximal row. This displacement occurs as a result of a scaphoid fracture or a scapholunate dislocation, and if the force is severe, a perilunate dislocation occurs (Browner, 1998). Trans-scaphoid perilunate fracture-dislocation is slightly more common than perilunate dislocation. Different posttraumatic deformity patterns can cause the lunate to lose its linear relationship with the capitate and to tilt dorsally or volarly, resulting in a collapse deformity. The most common collapse deformity is caused by the lunate dorsiflexing on the radius. This is compensated by the capitate flexing volarly. This deformity is also known as the dorsiflexed intercalated segment instability pattern (DISI). DISI normally occurs in unrecognized scaphoid subluxations or scaphoid fractures. The opposite type of deformity is known as volar intercalated segment instability pattern (VISI). Although VISI can be seen in healthy patients with lax ligaments, posttraumatically, it is a result of the lunate flexing volarly on the radius as the capitate tilts dorsally (Lichtman, 1997; Linscheid, 1972). VISI also is a sign of midcarpal instability or lunotriquetral injury. Mayfield and coworkers have classified wrist dislocation as follows (see Image 5):
CLINICALHistoryThe typical history is one of an athlete who has fallen on an outstretched hand to break a fall or who has mistimed a landing, as in gymnastics (Ried, 1992). The patient usually presents with vague wrist pain and the sensation of clicks or clunks. Patients may also complain of decreased grip strength with minimal pain. Localized pain is sometimes reported. Physical
Causes
DIFFERENTIALSCarpal Bone Injuries Hamate Fracture Hand Dislocation Metacarpal Fracture and Dislocation
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Drug Name | Ibuprofen (Ibuprin, Advil, Motrin) |
|---|---|
| Description | DOC for patients with mild to moderate pain. Inhibits inflammatory reactions and pain by decreasing prostaglandin synthesis. |
| Adult Dose | 400 mg PO q4-6h, 600 mg PO q6h, or 800 mg PO q8h while symptoms persist; not to exceed 3.2 g/d |
| Pediatric Dose | 20-70 mg/kg/d PO divided tid/qid; start at lower end of dosing range and titrate; not to exceed 2.4 g/d |
| Contraindications | Documented hypersensitivity; peptic ulcer disease, recent GI bleeding or perforation, renal insufficiency, or high risk of bleeding |
| Interactions | Coadministration with aspirin increases risk of serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT with concurrent anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Category D in third trimester of pregnancy; caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in coagulation abnormalities or during anticoagulant therapy |
| Drug Name | Flurbiprofen (Ansaid) |
|---|---|
| Description | May inhibit cyclo-oxygenase enzyme, which in turn inhibits prostaglandin biosynthesis. These effects may result in analgesic, antipyretic, and anti-inflammatory activities. |
| Adult Dose | 200-300 mg/d PO divided bid/qid |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity |
| Interactions | Coadministration with aspirin increases risk of serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT with concurrent anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | Category D in third trimester of pregnancy; acute renal insufficiency, interstitial nephritis, hyperkalemia, hyponatremia, and renal papillary necrosis may occur; patients with preexisting renal disease or compromised renal perfusion are at risk of acute renal failure; leukopenia occurs rarely, is transient, and usually resolves during therapy; persistent leukopenia, granulocytopenia, or thrombocytopenia warrants further evaluation and may require discontinuation of the drug |
| Drug Name | Ketoprofen (Oruvail, Orudis, Actron) |
|---|---|
| Description | For relief of mild to moderate pain and inflammation. Small initial doses are indicated in small or elderly patients and in those with renal or liver disease. Doses >75 mg do not increase therapeutic effects. Administer high doses with caution, and closely observe patient for response. |
| Adult Dose | 25-50 mg PO q6-8h prn; not to exceed 300 mg/d |
| Pediatric Dose | <3 months: Not established 3 months to 12 years: 0.1-1 mg/kg PO q6-8h 12 years: Administer as in adults |
| Contraindications | Documented hypersensitivity |
| Interactions | Coadministration with aspirin increases risk of serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT with concurrent anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Category D in third trimester of pregnancy; caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in coagulation abnormalities or during anticoagulant therapy |
| Drug Name | Naproxen (Naprelan, Aleve, Anaprox, Naprosyn) |
|---|---|
| Description | For relief of mild to moderate pain. Inhibits inflammatory reactions and pain by decreasing activity of cyclo-oxygenase, which is responsible for prostaglandin synthesis. |
| Adult Dose | 250-500 mg PO bid; may increase to 1.5 g/d for limited periods |
| Pediatric Dose | <2 years: Not established >2 years: 2.5 mg/kg/dose PO; not to exceed 10 mg/kg/d |
| Contraindications | Documented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency |
| Interactions | Coadministration with aspirin increases risk serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT with concurrent anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Category D in third trimester of pregnancy; acute renal insufficiency, interstitial nephritis, hyperkalemia, hyponatremia, and renal papillary necrosis may occur; patients with preexisting renal disease or compromised renal perfusion risk acute renal failure; leukopenia occurs rarely, is transient, and usually resolves during therapy; persistent leukopenia, granulocytopenia, or thrombocytopenia warrants further evaluation and may require discontinuation of the drug |
| Drug Name | Celecoxib (Celebrex) |
|---|---|
| Description | Inhibits primarily COX-2. COX-2 is considered an inducible isoenzyme, induced during pain and inflammatory stimuli. Inhibition of COX-1 may contribute to NSAID GI toxicity. At therapeutic concentrations, COX-1 isoenzyme is not inhibited; thus, GI toxicity may be decreased. Seek lowest dose of celecoxib for each patient. |
| Adult Dose | 200 mg/d PO qd; alternatively, 100 mg PO bid |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity |
| Interactions | Coadministration with fluconazole may cause increase in celecoxib plasma concentrations because of inhibition of celecoxib metabolism; coadministration of celecoxib with rifampin may decrease plasma celecoxib concentrations |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | Pregnancy category D in third trimester; may cause fluid retention and peripheral edema; caution in compromised cardiac function, hypertension, conditions predisposing patient to fluid retention; caution in severe heart failure and hyponatremia because may deteriorate circulatory hemodynamics; NSAIDs may mask usual signs of infection; caution in the presence of existing controlled infections; evaluate therapy when symptoms or laboratory results suggest liver dysfunction |
Pain control is essential to providing the quality of care for patients with wrist dislocations. Pain control ensures the patient's comfort and aids in physical therapy regimens. Many analgesics have sedating properties that benefit patients with fractures. Hydrocodone and oxycodone preparations are generally more effective and better tolerated than other narcotic-acetaminophen combinations, such as those containing codeine.
| Drug Name | Acetaminophen with codeine (Tylenol-3) |
|---|---|
| Description | Indicated for the treatment of mild to moderate pain. |
| Adult Dose | 30-60 mg/dose PO q4-6h based on codeine content or 1-2 tab q4h; not to exceed 4 g/d of acetaminophen |
| Pediatric Dose | 0.5-1 mg/kg/dose PO q4-6h based on codeine content; 10-15 mg/kg/dose based on acetaminophen content; not to exceed 2.6 g/d of acetaminophen |
| Contraindications | Documented hypersensitivity |
| Interactions | Toxicity of codeine increases with CNS depressants, tricyclic antidepressants, MAOIS, neuromuscular blockers, CNS depressants, phenothiazines, and narcotic analgesics; rifampin can reduce analgesic effects; coadministration with barbiturates, carbamazepine, hydantoins, and isoniazid may increase hepatotoxicity |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | Caution in patients dependent on opiates because this substitution may result in acute opiate-withdrawal symptoms; caution in severe renal or hepatic dysfunction; hepatotoxicity with acetaminophen possible with various dose levels in those with chronic alcoholism; severe or recurrent pain or high or continued fever may indicate serious illness; many OTC products contain acetaminophen, and combined use may result in cumulative acetaminophen doses exceeding recommended maximum dose |
| Drug Name | Hydrocodone and acetaminophen (Vicodin, Norcet, Lortab, Lorcet-HD) |
|---|---|
| Description | Drug combination indicated for moderate to severe pain. |
| Adult Dose | 1-2 tab or cap PO q4-6h prn pain |
| Pediatric Dose | <12 years: 10-15 mg/kg acetaminophen/dose PO q4-6h prn; not to exceed 2.6 g/d acetaminophen >12 years: 750 mg acetaminophen PO q4h; not to exceed 10 mg hydrocodone bitartrate per dose or 5 doses/24 h |
| Contraindications | Documented hypersensitivity; high-altitude cerebral edema or elevated intracranial pressure |
| Interactions | Coadministration with phenothiazines may decrease analgesic effects; toxicity increases with CNS depressants or tricyclic antidepressants |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | Tablets contain metabisulfite, which may cause hypersensitivity; caution in patients dependent on opiates since this substitution may result in acute opiate-withdrawal symptoms; caution in severe renal or hepatic dysfunction |
Athletes with wrist injuries are advised not to return to play until full recovery has been achieved.
Wrist injuries can be prevented by implementing proper technique; maintaining good strength; maintaining good flexibility; and, if the sport permits, using wrist guards.
If the diagnosis is established early (<3 mo) and if the proper treatment is administered, the prognosis is excellent.
Athletes should be educated about how to recognize wrist injuries. Seeking early medical attention for wrist injuries is important and should be emphasized to athletes. Proper technique, flexibility, and strengthening should also be emphasized.
For excellent patient education resources, visit eMedicine's Breaks, Fractures, and Dislocations Center. Also, see eMedicine's patient education article, Wrist Injury.
| Media file 1: Lunate dislocation. Posteroanterior projection of the wrist showing the pie shape of the lunate. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 2: Perilunate dislocation. On the posteroanterior radiograph, crowding is evident between the proximal and distal carpal bones. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 3: Perilunate dislocation. The lunate is in a normal anatomic position with respect to the radius. The rest of the carpal bones are displaced dorsally. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 4: Scapholunate dislocation. The scapholunate space usually is greater than 4 mm, a scenario also known as the Terry-Thomas sign. Rotation of the scaphoid causes the scaphoid to be viewed end-on, producing the classic signet-ring sign. | |
![]() | View Full Size Image | Media type: X-RAY |
| Media file 5: Progressive perilunar instability pattern reported by Mayfield et al. Stage I involves scaphoid instability; stage II, scaphoid and capitate instability; stage III, scaphoid, capitate, and triquetrum instability; and stage IV, lunate dislocation. | |
![]() | View Full Size Image | Media type: Image |
| Media file 6: On a normal lateral radiograph, the 4 Cs should be easily visualized. The 4 Cs are the convexity of the distal radius, the convexity and the concavity of the lunate, and the convexity of the capitate. A longitudinal axis aligns the radius, the lunate, the capitate, and the third metacarpal bone. The scapholunate angle is normally 30-60°. | |
![]() | View Full Size Image | Media type: Image |
Article Last Updated: Feb 10, 2006